Invesco Biotechnology & Genome ETF (PBE)'s 30-day implied volatility (IV30) was 26.0% at the close on October 30, 2026, up from 25.2% the day before, against a 52-week range of 13.8% to 29.4%. Its 20-day historical volatility was 26.6%.
Data as of October 30, 2026.